Search for: "Novartis Pharmaceuticals Inc" Results 121 - 140 of 393
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Apr 2016, 8:26 am by Tom Lamb
These medications are available by prescription and over-the-counter (OTC) from various pharmaceutical companies, for example: PRILOSEC (omeprazole magnesium) | prescription drug | AstraZeneca LPPRILOSEC OTC (omeprazole magnesium) | over-the-counter | Procter & Gamble Manufacturing Co.PREVACID (lansoprazole) | prescription drug | Takeda Pharmaceuticals America, Inc.PREVACID 24 HR (lansoprazole) | over-the-counter | Novartis Consumer Health, Inc.NEXIUM (esomeprazole… [read post]
5 Mar 2024, 10:55 am by Evangelina Cantu
AbbVie, Inc., et al., Adventist Health System, a 340B covered entity, is suing pharmaceutical manufacturers AbbVie, AstraZeneca, Novartis, Sanofi, and Sandoz alleging that the manufacturers caused violations of the False Claims Act and various state anti-fraud laws when calculating the 340B price for drugs with price increases that outpaced inflation. [read post]
1 Apr 2011, 8:54 pm by Andrew W. Torrance
  Later, he helped the National Biodiversity Institute of Costa Rica ("INBio") negotiate an agreement with pharmaceutical company Merck & Co., Inc., under which INBio received a $1,000,000 payment and $135,000 in scientific laboratory equipment in exchange for bioprospecting for, and preparing chemical extracts of, promising natural chemicals from Costa Rican rainforest organisms. [read post]
1 Mar 2011, 1:34 pm by John Elwood
Kuzinski (No. 10-459) and Novartis Pharmaceuticals Corp. v. [read post]
17 Aug 2009, 8:01 am
For example, Teva has challenged and prevailed over Novartis, concerning the right to manufacture a generic copy of Lotrel, even though Novartis’ patent is valid until 2017. [read post]
17 Aug 2009, 8:01 am
For example, Teva has challenged and prevailed over Novartis, concerning the right to manufacture a generic copy of Lotrel, even though Novartis’ patent is valid until 2017. [read post]
17 Jul 2012, 4:40 am by Michelle Yeary
  Back in 2009, the defendants (AstraZeneca, Novartis & GlaxoSmithKline) who went to trial were manufacturers of brand name pharmaceuticals. [read post]
15 Feb 2011, 4:06 am by Andrew Frisch
Universal Commc’ns of Miami, Inc., 591 F.3d 101, 106 (2d Cir.2010) (in resolving whether advertising sales director was an administrative or sales worker in the publishing industry “a careful consideration of [employer's] business model provides some clarity”). [read post]
5 Apr 2023, 5:18 am by Annsley Merelle Ward
Similarly, Hacon HHJ stated in Teva v Novartis [2022] EWHC 2847 (Pat): “It seems that there was little or no interaction between Novartis’ three experts during the preparation of their evidence. [read post]
18 Mar 2014, 9:13 am by Saurabh Anand
  In addition, in July 2010, FDA issued an untitled letter to Novartis Pharmaceuticals Corporation relating to the “Facebook Share” widget on its Tasigna® product website. [read post]
31 Dec 2008, 6:51 pm
Recent news reports have allowed us to add thirteen biotech/pharma companies and a trade group to the list: • The Pharmaceutical Research and Manufacturers of America (PhRMA), which has more than 30 members including Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Johnson & Johnson, Merck & Co., Novartis Corp., Pfizer Inc., and Sanofi-Aventis SA, spent more than $5.4 million on third quarter lobbying (see… [read post]